Recent developments in pradimicin-benanomicin and triazole antibiotics

Expert Opinion on Investigational Drugs

Volumn 6, Issue 2, 1997, Pages 129-145

  Fung Tomc, J C ^a   Bonner, D P ^a  

^a BRISTOL MYERS SQUIBB PHARMACEUTICAL RESEARCH INSTITUTE   (United States)

Author keywords

azole; benanomicin; BMS 181184; D0870; ER 30346; fluconazole; itraconazole; p radimicin; Sch 56592; voriconazole

Indexed keywords

2 (2,4 DIFLUOROPHENYL) 1 [3 [2 [4 (2,2,3,3 TETRAFLUOROPROPOXY)PHENYL]VINYL] 1,2,4 TRIAZOL 1 YL] 3 (1,2,4 TRIAZOL 1 YL) 2 PROPANOL; 4 [4 [4 [4 [[5 (2,4 DIFLUOROPHENYL)TETRAHYDRO 5 (1H 1,2,4 TRIAZOL 1 YLMETHYL)FURAN 3 YL]METHOXY]PHENYL] 1 PIPERAZINYL] PHENYL] 2,4 DIHYDRO 2 (1 ETHYL 2 HYDROXYPROPYL) 3H 1,2,4 TRIAZOLE 3 ONE; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BENANOMICIN A DERIVATIVE; BMS 181184; BMY 28864; CYTOCHROME P450 ISOENZYME; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; MANNAN; PHENOBARBITAL; PHENYTOIN; POSACONAZOLE; PRADIMICIN DERIVATIVE; RAVUCONAZOLE; RIFAMPICIN; STEROL 14ALPHA DEMETHYLASE; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG; VORICONAZOLE;

ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ASPERGILLUS; CANDIDA; CELL MEMBRANE; CLINICAL TRIAL; CRYPTOCOCCUS NEOFORMANS; DRUG MECHANISM; DRUG METABOLISM; HEADACHE; HUMAN; IMMUNE DEFICIENCY; MYCOSIS; NONHUMAN; PNEUMOCYSTIS CARINII; RASH; REVIEW; VISUAL DISORDER;

EID: 0031058258     PISSN: 13543784     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543784.6.2.129     Document Type: Review

References (148)